Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01755221 · ClinicalTrials.gov registry record
Positive Predictive Value of the Dx-pH Probe for Predicting PPI Response in LPR
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 42
- Enrollment target
NCT01755221 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 42 participants.
The verdict
NCT01755221 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 42 participants
- Enrollment target
Study Summary
The purpose of this research study is to better understand whether information obtained from a pH probe can help physicians predict whether a patient will respond to the medication that is prescribed for laryngopharyngeal reflux (LPR). The current treatment given to individuals who are diagnosed with LPR is a course of proton pump inhibitor (PPI) medication. Subjects who agree to participate in this study will have a small flexible tube (about the width of a piece of cooked spaghetti) placed in their throat. This tube measures the pH in the throat over a period of 24 hours and helps physicians study the relationship between pH level, LPR symptoms, and the effectiveness of PPI therapy. This study may help physicians find out if certain symptoms or characteristics can help them predict if the PPI medication will be effective for each patient. After probe removal, subjects will receive compensation. They will return to the clinic at their regularly scheduled follow-up visit with the physician, 8 to 12 weeks after starting the PPI medication. At that time, subjects can choose to participate in an optional probe placement.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2012-08 |
| Est. Completion | 2016-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01755221
The ClinicalTrials.gov registry entry for NCT01755221 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01755221 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01755221 about?
NCT01755221 is a clinical study titled "Positive Predictive Value of the Dx-pH Probe for Predicting PPI Response in LPR". The purpose of this research study is to better understand whether information obtained from a pH probe can help physicians predict whether a patient will respond to the medication that is prescribed for laryngopharyngeal reflux (LPR). The current treatment given to individuals who are diagnosed wit...
What is the current status of trial NCT01755221?
This trial is currently completed. The enrollment target is 42 participants. The study started on 2012-08. Estimated completion is 2016-08.
Who is sponsoring clinical trial NCT01755221?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.